| Literature DB >> 25240149 |
M Nozzi1, M Del Torto2, F Chiarelli2, L Breda2.
Abstract
Leishmaniasis is a group of diseases caused by the protozoa Leishmania, endemic in the Mediterranean countries. Clinical manifestations can be divided into three different forms: cutaneous leishmaniasis, mucosal leishmaniasis and the visceral leishmaniasis, the most severe form which is potentially lethal if untreated. Immunology and pathogenesis are complex: many different aspects of immune response, resistance and susceptibility to Leishmania have been studied but many others remain to be clarified. The gold standard in diagnosis of visceral Leishmaniasis is the presence of amastigotes in bone marrow or tissue sections. Patients can be initially misdiagnosed as having an autoimmune disease because it may mimic diseases like systemic lupus erythematosus, autoimmune hepatitis, dermatomyositis or others disorders. As in pediatric age the risk of life-threatening complications is very high, leishmaniasis, must be kept in mind to the clinician, in order to avoid wrong diagnosis and an inappropriate immunosuppressive therapy.Entities:
Keywords: Autoimmunity; Cytokines; Leishmaniasis; Pediatric age; Systemic lupus erythematosus
Mesh:
Year: 2014 PMID: 25240149 DOI: 10.1016/j.cellimm.2014.08.004
Source DB: PubMed Journal: Cell Immunol ISSN: 0008-8749 Impact factor: 4.868